Itamar Medical Ltd Receivables Turnover Ratio (ITMR), from the fourth quarter 2020 to the fourth quarter 2019 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Itamar Medical Ltd   (ITMR)
 

Itamar Medical Ltd Accounts Receivables Turnover Ratio from the fourth quarter 2020 to the fourth quarter 2019

Quarterly Results, Trends, Rankings, Statistics


Itamar Medical Ltd 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2020 to a ratio of 4.91, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the fourth quarter 2020. Average receivable collection period, for the Itamar Medical Ltd in Dec 31 2020 quarter, has decreased to 74 days, compared to 90 days, in the 0 quarter.

If we take a look into Healthcare sector 422 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2020 from 1646 to 3170.

What is Receivable Turnover Ratio?
What is Itamar Medical Ltd Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ITMR Receivables Turnover Ratio (Dec 31 2020)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2019)
IV. Quarter
Y / Y Receivable Change 8.35 % 8.44 % 8.35 % 8.35 % 29.35 %
Y / Y Revenue Change 31.28 % 36.06 % - - 29.22 %
Receivable Turnover Ratio (TTM) 4.91 4.06 3.86 3.94 4.02
ITMR's Total Ranking # 3170 # 1646 # 1645 # 0 # 3159
Accounts Receivable average collection period days 74 90 95 93 91
Seq. Receivable Change -0.08 % 0.08 % 0 % 8.35 % 0 %
Seq. Revenue Change 273.07 % - - - 286.67 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 127
Healthcare Sector # 423
Overall Market # 3170

Receivable Turnover Ratio Statistics
High Average Low
3.87 3.42 3.19
(Dec 31 2020)   (Dec 31 2019)





ITMR Company Profile • Back to ITMR Efficiency Comparisons • Compare ITMR Receivables Turnover Ratio to its Competitors

Financial Statements
Itamar Medical Ltd 's Accounts Receivable $ 11 Millions Visit ITMR's Balance sheet
Itamar Medical Ltd 's Sales TTM $ 52 Millions Visit ITMR's Income Statement
Sources of ITMR's Revenues Visit ITMR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ITMR's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ITMR's Growth Rates ITMR's Roa ITMR's Inventory Turnover Ratio ITMR's Dividend Comparisons
ITMR's Profitability Ratios ITMR's Roi ITMR's Asset Turnover Ratio ITMR's Dividend Growth
ITMR's Valuation Ratios ITMR's Roe ITMR's Financial Strength Ratios ITMR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2020, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2020 Receivable at quarter ending Dec 31 2020
Xencor Inc  13.36 $ 122.694  Millions$ 9.182  Millions
Alpha Pro Tech Ltd   13.13 $ 102.700  Millions$ 7.823  Millions
Protalix Biotherapeutics inc   13.05 $ 62.898  Millions$ 4.821  Millions
Patterson Companies Inc   12.98 $ 5,636.734  Millions$ 434.166  Millions
Arrowhead Pharmaceuticals Inc   12.96 $ 79.840  Millions$ 6.162  Millions
Prothena Corporation Public Limited Company  12.78 $ 0.853  Millions$ 0.067  Millions
Travere Therapeutics Inc   12.57 $ 198.321  Millions$ 15.778  Millions
Ontrak Inc   12.47 $ 82.837  Millions$ 6.640  Millions
Kadmon holdings inc   12.29 $ 8.288  Millions$ 0.675  Millions
Dicerna Pharmaceuticals Inc   12.00 $ 164.307  Millions$ 13.688  Millions
Fate Therapeutics Inc   12.00 $ 31.434  Millions$ 2.619  Millions
Bellicum Pharmaceuticals Inc   11.89 $ 0.892  Millions$ 0.075  Millions
Lifeloc Technologies Inc   11.46 $ 6.357  Millions$ 0.555  Millions
Capforce Inc   11.44 $ 4.214  Millions$ 0.368  Millions
Outset Medical Inc   11.44 $ 49.935  Millions$ 4.366  Millions
National Healthcare Corp  11.41 $ 1,028.217  Millions$ 90.131  Millions
Ultragenyx Pharmaceutical Inc   11.40 $ 271.030  Millions$ 23.769  Millions
Surmodics Inc   11.36 $ 94.545  Millions$ 8.321  Millions
Sanara Medtech Inc   11.29 $ 18.554  Millions$ 1.644  Millions
Intellia Therapeutics Inc   11.27 $ 57.994  Millions$ 5.145  Millions
Integrated Biopharma Inc  11.24 $ 56.595  Millions$ 5.035  Millions
Musclepharm Corporation  11.23 $ 64.440  Millions$ 5.737  Millions
Novabridge Biosciences  11.18 $ 223.599  Millions$ 20.000  Millions
Morphic Holding inc   11.12 $ 44.945  Millions$ 4.041  Millions
Allied Healthcare Products inc   11.05 $ 37.901  Millions$ 3.431  Millions
Sunwin Stevia International Inc.  10.98 $ 25.297  Millions$ 2.304  Millions
Taiwan Liposome Company Ltd   10.97 $ 3.630  Millions$ 0.331  Millions
American Bio Medica Corporation  10.93 $ 4.147  Millions$ 0.379  Millions
Strongbridge Biopharma plc  10.91 $ 30.731  Millions$ 2.818  Millions
Teladoc Health Inc   10.87 $ 1,093.962  Millions$ 100.677  Millions

Date modified: 2026-08-29T01:15:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.